高级检索
刘丽, 张倩文, 农程, 张曦, 徐小婷, Mohammed Ismail, 肖莉, 江振洲, 张陆勇, 孙丽新. LncRNA调控肝脏疾病中信号转导通路的研究进展[J]. 中国药科大学学报, 2020, 51(3): 277-286. DOI: 10.11665/j.issn.1000-5048.20200304
引用本文: 刘丽, 张倩文, 农程, 张曦, 徐小婷, Mohammed Ismail, 肖莉, 江振洲, 张陆勇, 孙丽新. LncRNA调控肝脏疾病中信号转导通路的研究进展[J]. 中国药科大学学报, 2020, 51(3): 277-286. DOI: 10.11665/j.issn.1000-5048.20200304
LIU Li, ZHANG Qianwen, NONG Cheng, ZHANG Xi, XU Xiaoting, Mohammed Ismail, XIAO Li, JIANG Zhenzhou, ZHANG Luyong, SUN Lixin. Research progress of lncRNA regulating signal transduction pathway in liver diseases[J]. Journal of China Pharmaceutical University, 2020, 51(3): 277-286. DOI: 10.11665/j.issn.1000-5048.20200304
Citation: LIU Li, ZHANG Qianwen, NONG Cheng, ZHANG Xi, XU Xiaoting, Mohammed Ismail, XIAO Li, JIANG Zhenzhou, ZHANG Luyong, SUN Lixin. Research progress of lncRNA regulating signal transduction pathway in liver diseases[J]. Journal of China Pharmaceutical University, 2020, 51(3): 277-286. DOI: 10.11665/j.issn.1000-5048.20200304

LncRNA调控肝脏疾病中信号转导通路的研究进展

Research progress of lncRNA regulating signal transduction pathway in liver diseases

  • 摘要: 肝脏疾病的发病率逐年上升,由于肝脏疾病发病诱因复杂和发病机制尚未阐明,治愈率不够理想,迫切需要明确其作用机制以找到更有效的治疗靶点与药物。长链非编码RNA( long non-coding RNA,lncRNA)作为一种长度超过200 nt的非编码RNA,是近年来肝脏疾病的研究热点。本文以肝脏疾病中主要的信号转导通路为主线,对近年来lncRNA调控肝脏疾病相关信号通路的最新研究进展进行归纳总结,详细阐述lncRNA通过调节肝脏疾病中关键的信号通路,参与细胞增殖、凋亡、侵袭、迁移等多种生理过程,从而促进肝脏疾病的发生发展,为肝脏疾病的机制研究提供新的思路,为寻找治疗肝脏疾病的新靶点及生物标志物提供新的研究方向。

     

    Abstract: The incidence of liver disease is increasing year by year. Due to the complex predisposing factors and unclear pathogenesis of liver diseases, the cure rate is still not ideal, so it is urgent to clarify its mechanism to find more effective therapeutic targets and drugs. Long non-coding RNA (lncRNA), as a non-coding RNA with a length of more than 200 nt, is a research hotspot in liver diseases in recent years. Focusing on the main signal transduction pathways in liver diseases, this review mainly summarizes the latest research progress of lncRNA in regulating liver disease-related signaling pathways, and elaborates that lncRNAs participate in various physiological processes such as cell proliferation, apoptosis, invasion, and migration by regulating key signaling pathways in liver diseases, thereby promoting the occurrence and development of liver diseases. This review provides new ideas for studying the mechanism of liver diseases, and new directions for finding new targets and biomarkers for the treatment of liver diseases.

     

/

返回文章
返回